Press Release Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma XPOVIO® (selinexor) is the first and only exportin 1 (XPO1) inhibitor approved… CISION PRNewswireDecember 6, 2023
Press Release Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8% JINAN, China, Dec. 6, 2023 /PRNewswire/ — Qilu Pharmaceutical presented the latest… CISION PRNewswireDecember 6, 2023
Press Release Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas KUALA LUMPUR, Malaysia, Dec. 6, 2023 /PRNewswire/ — AstraZeneca’s Koselugo (selumetinib) is… CISION PRNewswireDecember 6, 2023
Press Release Tech OKX Ventures Joins Ethereum Climate Platform As a Launch Partner to Advance Sustainability in Web3 SINGAPORE, Dec. 6, 2023 /PRNewswire/ — OKX Ventures, the investment arm of… CISION PRNewswireDecember 6, 2023
Business Press Release Tech Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024 BEIJING, Dec. 6, 2023 /PRNewswire/ — Uxin Limited ("Uxin" or the "Company")… CISION PRNewswireDecember 6, 2023
Business Press Release Tech Qianhai's Intensive Digital Industrial Layout to Facilitate the Development of the GBA SHENZHEN, China, Dec. 6, 2023 /PRNewswire/ — Digital trade is one of… CISION PRNewswireDecember 6, 2023
Press Release Tech Systecon announces new CEO and changes to the Board of Directors STOCKHOLM, Dec. 6, 2023 /PRNewswire/ — The Systecon Group has embarked on… CISION PRNewswireDecember 6, 2023
Business Lifestyle Press Release Tech N mobile Makes Its Disruptive Debut – Probably the best value travel & lifestyle mobile brand in Hong Kong HONG KONG, Dec. 6, 2023 /PRNewswire/ — HKBN is excited to unveil… CISION PRNewswireDecember 6, 2023
